(19)
(11) EP 3 054 301 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 A1)

(48) Corrigendum issued on:
05.10.2016 Bulletin 2016/40

(88) Date of publication A3:
10.08.2016 Bulletin 2016/32

(43) Date of publication:
10.08.2016 Bulletin 2016/32

(21) Application number: 15003574.9

(22) Date of filing: 03.06.2011
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
C07K 14/775(2006.01)
 G01N 33/53(2006.01)
C07K 14/00(2006.01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 03.06.2010 US 351183 P
08.11.2010 US 411280 P

(62) Application number of the earlier application in accordance with Art. 76 EPC:
11725846.7 / 2577315

(71) Applicant: IDEXX LABORATORIES, INC.
Westbrook, Maine 04092 (US)

(72) Inventors:
  • Yerramilli, Mahalakshmi
    Falmouth, ME 04105 (US)
  • Atkinson, Michael Randolph
    Gorham, ME 04038 (US)
  • Yerramilli, Murthy V.S.N.
    Falmouth, ME 04105 (US)

(74) Representative: Müller-Boré & Partner Patentanwälte PartG mbB 
Friedenheimer Brücke 21
80639 München
80639 München (DE)

 
Remarks:
This application was filed on 03-12-2015 as a divisional application to the application mentioned under INID code 62.
Remarks:
Claims filed after the date of filing of the application / after the date of receipt of the divisional application (Rule 68(4) EPC).
 


(54) MARKERS FOR RENAL DISEASE


(57) This invention provides reagents and methods for diagnosing renal disease. Differential levels of inosine metabolite, and proteins: apolipoprotein C-I, apolipoprotein C-II, fibrinogen alpha chain, or fibrinogen A-alpha chain, kininogen, Inter-Alpha Inhibitor H4 (ITIH4), keratin Type I cytoskeletol 10 cystatin A, cystatin B and other polypeptides and fragments thereof provide biomarkers of renal disease and are described herein.